ISIN
CH0346177709
Ticker
OBSN
Sector
Sub-Industry
Country
Switzerland
Year Founded
2012
Founded in November 2012, ObsEva is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy. We believe our expertise has led to the development of new and innovative therapies that have the potential to improve patient outcomes in reproductive health.
Worldwide
Date | Trading entity / Person | Association | Trade type | Volume |
---|---|---|---|---|
17.03.2022 | None | Non-Executive member | Buy | CHF 2,058.00 |
16.03.2022 | None | Non-Executive member | Buy | CHF 27,010.00 |
15.03.2022 | None | Non-Executive member | Buy | CHF 23,642.00 |
08.02.2022 | None | Non-Executive member | Buy | CHF 64,161.00 |
01.02.2022 | None | Non-Executive member | Buy | CHF 70,716.00 |
24.01.2022 | None | Non-Executive member | Buy | CHF 69,748.00 |
11.01.2022 | None | Non-Executive member | Buy | CHF 183,535.00 |
10.01.2022 | None | Non-Executive member | Buy | CHF 177,643.00 |
CH0346177709
549300PNZ0UEJVKN1618
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.